BPC-157 and TB-500, the “Wolverine Shot”: What They Are, What the Evidence Says, and How We Approach Them

BPC-157 is a synthetic chain of 15 amino acids modeled on part of a protein found in human gastric juice. It has been studied for decades, almost entirely in animals: rodent models of tendon, ligament and muscle injury, of gut inflammation and ulcers, and of blood-vessel growth. Those studies are where the reputation comes from. Human evidence is a different story. A 2025 systematic review of the orthopaedic literature found hundreds of laboratory and animal papers and a single clinical study; a 2026 review of the human studies found only a few very small ones. No study has established a dose, a duration or a safety profile in people. There is no FDA-approved product containing BPC-157.

TB-500 is a synthetic fragment of thymosin beta-4, a protein present in most human cells that is involved in how cells move and organize during tissue repair. The full protein has been studied in early human trials for unrelated uses, such as eye and skin wounds. The shorter fragment sold as TB-500 has mostly animal data, again in injury and repair models; a 2026 review written for sports-medicine physicians found no human orthopaedic data for it. There is no FDA-approved product containing TB-500.

The pairing of BPC-157 and TB-500 goes by the nickname “Wolverine shot” among patients and pharmacies. We use the name because it is the name people search for, and you should be able to find a straight answer when you do. It is a nickname, not a description of what the pairing does. The two are paired on the theory that they act on different parts of tissue repair; that theory comes from animal studies and from clinical experience, not from human trials of the combination. No one should promise you what the name implies, and we won't.

One practical point: the October 2026 policy covers each peptide only as its own single-ingredient compounded product. It does not cover a product that mixes the two, so at a licensed pharmacy the “Wolverine shot” means two prescriptions, prepared separately.

At Peak Medical Wellness, nothing is prescribed from a website or a questionnaire. A peptide conversation starts with an in-person visit, and the provider is weighing:

• What you're trying to address, and whether a peptide is a reasonable thing to try for it. Many injuries and most gut symptoms have better-studied first steps. Sometimes the right answer is a referral, not a prescription.
• Your history. Because these peptides act on tissue growth and blood-vessel formation in animal studies, a provider will ask carefully about any history of cancer, and will not prescribe during pregnancy or breastfeeding.
• What else you take. Interactions have not been studied; that is itself a reason for caution.
• Labs. Baseline labs are drawn in our office when the provider wants them.
• Expectations. No one can promise you a result from a medication with this little human evidence, and we won't.

Known: injection-site reactions (redness, soreness) are the most common report. Unknown: nearly everything long-term. No regulator has reviewed these peptides for safety, and the FDA's own reviewers described the safety and effectiveness information as insufficient when the advisory committee considered them in July 2026. “Unknown” is not the same as “safe.”

If a provider here prescribes BPC-157 or TB-500, it is prepared by a licensed compounding pharmacy for you individually. It is a compounded drug: not FDA-approved, not reviewed by the FDA for safety, effectiveness or quality. The October 2026 policy requires the pharmacy to use an ingredient from an FDA-registered manufacturer with a certificate of analysis, to test what it makes, and to report serious side effects. Registration is not approval. Those conditions are the floor, not a guarantee. Our guide to the policy explains the rest, and our patient safety page describes how we choose pharmacies.

Vials sold as “research use only” are not made for human use, and nobody is checking the contents. A recent news investigation lab-tested a peptide bought from an unregulated seller and found no peptide in it. If you've been using an online product, bring it to your visit; your provider would rather know.

We plan to offer BPC-157 and TB-500, separately and as the pairing known as the “Wolverine shot,” by prescription once each has been through our clinical review and procedure process and our compounding pharmacy partner is supplying them under the policy's conditions. If you're interested, book a visit now; the evaluation is the same either way, and we'll tell you where availability stands.

New to peptides altogether? Start with our beginner's guide to peptide therapy, then come talk it through.